The emerging role of peripheral corticotropin-releasing hormone (CRH)
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Corticotropin-releasing hormone (CRH) is distributed in the brain and spinal cord and it has also been found in the myometrium, the endometrium, the placenta and diverse inflammatory sites. Traditionally, hypothalamic CRH has been considered to act indirectly in an anti-inflammatory fashion, since the end product of the hypothalamic-pituitary-adrenal axis is cortisol, a well-known anti-inflammatory compound. However, CRH produced at peripheral inflammatory sites may participate in an auto-/paracrine stimulation of inflammation. CRH in inflammatory sites seems to be involved in the activation of the Fas/Fas ligand system. Furthermore, locally produced embryonic and endometrial CRH plays a role in both the aseptic inflammatory process of implantation and the anti-rejection process that protects the fetus from the maternal immune system. There are two types of G protein-coupled CRH receptors, type 1 and 2. Pyrrolopyrimidine compounds, such as antalarmin, have been developed as CRH receptor antagonists. The systemic administration of antalarmin blocks pituitary CRH receptors and the CRH-induced secretion of adrenocorticotropin. Additonally, antalarmin has been shown to reduce the inflammatory-like reaction of the endometrium to the invading blastocyst, with a possible therapeutic potential as a non-steroidal inhibitor of pregnancy at its early stages.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
Lymphocyte responses and cytokines
Paul, W. E., & Seder, R. A. (1994) · Cell · doi:10.1016/0092-8674(94)90332-8 · Cited by 1,828
Expression cloning of a human corticotropin-releasing-factor receptor.
Chen, R., Lewis, K. A., Perrin, M. H., & Vale, W. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8967 · Cited by 927
Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates
Boumpas, D. T., Chrousos, G. P., Wilder, R. L., Cupps, T. R., & Balow, J. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-12-199312150-00007 · Cited by 778
Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans.
Mastorakos, G., Chrousos, G. P., & Weber, J. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263159 · Cited by 591
Self-citationNeuroendocrine-Immune Interactions
Epstein, F. H., & Reichlin, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310213291708 · Cited by 567
RIVIER, C., BROWNSTEIN, M., SPIESS, J., RIVIER, J., & VALE, W. (1982) · Endocrinology · doi:10.1210/endo-110-1-272 · Cited by 555
Autocrine or Paracrine Inflammatory Actions of Corticotropin-Releasing Hormone in Vivo
Karalis, K., Sano, H., Redwine, J., Listwak, S., Wilder, R. L., & Chrousos, G. P. (1991) · Science · doi:10.1126/science.1925600 · Cited by 482
Primary structure of corticotropin-releasing factor from ovine hypothalamus
Spiess, J., Rivier, J., Rivier, C., & Vale, W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6517 · Cited by 424
Research works printed but not linked: 1
- Mastorakos G., Silver P.B., Bouzas E.A., Caspi R.R., Chan C.C., Chrousos G.P. Immunoreactive corticotropin releasing hormone in experimental uveitis. Inv. Ophthalmol. Vis. Sci. 1992, 33: 933.
Cited by
Functions of corticotropin‐releasing hormone in anthropoid primates: From brain to placenta
Power, M. L., & Schulkin, J. (2006) · American Journal of Human Biology · doi:10.1002/ajhb.20521 · Cited by 70
Immunomodulatory Effects of Sex Hormones: Requirements for Pregnancy and Relevance in Melanoma
Enninga, E. A. L., Holtan, S. G., Creedon, D. J., Dronca, R. S., Nevala, W. K., Ognjanovic, S., & Markovic, S. N. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.01.006 · Cited by 72
Corticotropin releasing hormone and the immune/inflammatory response
Mastorakos, G., Karoutsou, E. I., & Mizamtsidi, M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02243 · Cited by 63
Self-citationHennessy, M. B., Deak, T., & Schiml-Webb, P. A. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.03.012 · Cited by 59
“Although CRF increases levels of glucocorticoids, which are well known for their anti-inflammatory actions, CRF itself has proinflammatory effects (Ilias & Mastorakos, 2003).”
Fatouros, I. G., Chatzinikolaou, A., Paltoglou, G., Petridou, A., Avloniti, A. A., Jamurtas, A. Z., Goussetis, E., Mitrakou, A., Mougios, V., Lazaropoulou, C., et al. (2010) · Stress · doi:10.3109/10253891003743432 · Cited by 62
“The cellular components of the I/I response consist of circulating nonlymphoid leucocytes, lymphocytes, and local immune accessory cells (Ilias and Mastorakos 2002).”
BackgroundSelf-citation
Metadata
- Authors
- Ilias, I., & Mastorakos, G.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Corresponding author
- Mastorakos, G.
- ORCID
- Mastorakos, G.
- Venue
- Journal of Endocrinological Investigation
- Published
- 2003-04
- Volume
- 26
- Issue
- 4
- Pages
- 364-371
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W2131552025
- Cited by
- 24
- References
- 66
- Citations by year
- 2026: 2 · 2025: 1 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 0.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- corticotropin-releasing factor, inflammation, Fas/Fas ligand, implantation, CRH receptors, antalarmin, CRH receptor antagonist, hypothalamic-pituitary-adrenal axis, endometrium, myometrium, pregnancy
- MeSH terms
- Animals, Corticotropin-Releasing Hormone, Female, Fetus, Humans, Hypothalamo-Hypophyseal System, Immune System, Immune Tolerance, Inflammation, Maternal-Fetal Exchange, Neurosecretory Systems, Embryo Implantation, Pituitary-Adrenal System, Pregnancy, Reproduction, Tissue Distribution, Neuroimmunomodulation, Alternative Splicing, Protein Isoforms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.